Christman Lab

Biomaterials and regenerative medicine lab at UCSD | PI: Karen L. Christman | Prof. of Bioeng'g and Assoc. Dean for Faculty | co-EIC npj Regenerative Medicine

[Lammerding Lab @LammerdingLab]

This is the impact the recent cuts in federal funding have on biomedical research and human health. A new heart pump to save sick babies, which took 20+ year to develop, will be stopped short off helping patients, and the researchers fear for their jobs.
https://t.co/yDNAFleJew

[Mike “Let’s go Knicks!” Mitchell @MJMitchell_Lab]

Scientists fear Trump administration cuts to NIH could impact the health of Americans for generations - CBS News https://t.co/f8sBMRVqfE

[shyni varghese @shynivarghese]

I'm thrilled to share our latest research, just published in npj Regenerative Medicine. This study explores age-related changes in extracellular adenosine and how local adenosine delivery can promote in situ bone healing.
https://t.co/X5DDLEvxap

[Christman Lab @ChristmanLab]

Honored to be elected an AAAS fellow. I've been very fortunate to work with a great team at UC San Diego. Funding from @NIH has led to our work being translated to patients. Hoping this critical funding can continue so we can further impact patient lives.

[UCSD Engineering @UCSDJacobs]

Congratulations to #bioengineering Prof. Karen Christman @ChristmanLab, who was elected an @aaas fellow!
She is an expert in #hydrogels & #biomaterials that heal tissues inside the body.
https://t.co/ckCdA8CqbX
@ucsdbe

[Acta Biomaterialia @ActaBio]

Plan to attend! @ActaBio Awardee Session @SFBiomaterials Annual Meeting THURSDAY APRIL 10, 4pm 👏🎉 Grand Ballroom

Talks by the Gold & Silver Medalists: @ChristmanLab & Fred Schoen, & the Mary Fortune Awardee @cosgriffhernan & their guests @NatalieArtzi

https://t.co/CJJQMaWESa

[Michael Lin, MD PhD 🧬 @michaelzlin]

Our NIH grant to discover coronavirus antiviral meds was terminated today.

With this grant, we had developed a better SARSCoV2 inhibitor than Paxlovid, and we recently discovered an improved drug that looks better than Pfizer's own second-generation inhibitor.

[Acta Biomaterialia @ActaBio]

Plan to attend! @ActaBio Awardee Session @SFBiomaterials 50th Annual Meeting THURSDAY APRIL 10, 4pm CT 👏🎉

Talks by the Gold & Silver Medalists: @ChristmanLab and Fred Schoen, & the Mary Fortune Awardee @cosgriffhernan & their guests @NatalieArtzi

https://t.co/CJJQMaWESa

[Rommie Amaro @RommieAmaro]

All NIH summer internship programs across all institutes cancelled 😡

Cutting into our future workforce-

Our future Nobel prize winners!

@elonmusk How does this help American competitiveness?

[AIMBE @aimbe]

AIMBE is looking for biomedical researchers to share how recent policies have disrupted their grants/work: https://t.co/irVyvElvva

Your personal anecdotes help us convey to Members of Congress the devastating impact of these changes.

Your responses can remain anonymous.

[The Transmitter @_TheTransmitter]

A large portion of grants awarded by the U.S. National Institutes of Health cannot be funded for the foreseeable future because of an indefinite hold on submissions to the Federal Register, according to an email reviewed by The Transmitter.
By @avaskham
https://t.co/X77uE19e0J

[UC San Diego Bioengineering @ucsdbe]

Congratulations to @UCSDJacobs Bioengineering faculty member Prof. Brian Aguado on receiving the @SFBiomaterials Young Investigator Award! 🏆

[Olivier George @brainaddiction]

It's clear that many do not understand what @NIH-funded research does to improve health. It's time to revive a study published 10 years ago that provides incredible information about this. link in the comment

Every single new drug approved by the FDA from 2010–2016 was built on NIH-funded research—that’s all 210 drugs. But what the public sees is just the tip of the iceberg.

Pharma takes credit for the final product, but beneath each drug developed, there are ~20 years of basic research, and 90% of the cost is from basic research funded by the NIH, which discovers drug targets, understands disease mechanisms, and creates life-saving treatments.

Figuring out how cancer evades the immune system, how addiction rewires the brain, and how heart disease develops is the role of the NIH, creating the foundation for the breakthrough drugs that come 20 years later, and the NIH does all that with only 0.8% of the US budget.

Without NIH, there would be no cancer immunotherapy, no anti-overdose medication, no anti-heart attack or stroke medication, no cutting-edge treatments.

If NIH funding is cut, the iceberg will melt. That means fewer cures, more suffering, and more lives lost.

The science beneath the surface keeps us afloat.
Invest in NIH. Invest in life

[Ashish K. Jha @ashishkjha]

One falsehood folks spread is that vaccines haven't been tested against placebo

Not true

For example,

HPV vaccines have nearly eliminated cervical cancer in vaccinated populations

And here's one of many studies comparing it against placebo

https://t.co/vShHX0FVqv

[Farzad Mostashari @Farzad_MD]

1/ After residency at Mass General Hospital, I reported to Atlanta to meet my fellow CDC Epidemic Intelligence Service Officers.

I have never felt so intimidated by my peers

The best and the brightest, they were star clinicians, had served in disaster zones; MD/PhDs and MSF.

[Acta Biomaterialia @ActaBio]

Enjoy these articles from 2025 @ActaBio Gold Medalist Professor Frederick Schoen, Silver Medalist Professor Karen Christman & the Acta Mat Inc. Mary Fortune Global Diversity Medalist Professor Elizabeth Cosgriff-Hernandez: https://t.co/bCmJh8ywZY
@ChristmanLab @cosgriffhernan

[Michael Lin, MD PhD 🧬 @michaelzlin]

To be clear these jobs benefit not just the holder but all Americans. NIH funds train people in how to make discoveries to fight diseases such as cancer. Most of them then go to companies to continue the work.

Taxpayer money should be spent to benefit all; here it certainly is.

[Prof. Akiko Iwasaki @VirusesImmunity]

NIH indirect costs fund the backbone of research: maintaining labs, ensuring safety, and supporting admin work. These are essential for groundbreaking discoveries. Drastic cuts to NIH indirect rates are detrimental to academic biomedical research.

[Christman Lab @ChristmanLab]

Thanks for the great visit. Enjoyed hearing about all the cool work going on at @IRM_UPenn and @pennbioeng

[Riccardo Gottardi @RicGottardi]

Great talk by @ChristmanLab for today's @IRM_UPenn seminar, translating ECM magerials to the clinical reatment of heart failures, leaky blood vessels, pelvic floor disorders! Bioengineering in action! @ucsdbe @pennbioeng

[Marcy Zenobi-Wong @ZenobiWongLab]

My laboratory has an open position in osteochondral engineering

https://t.co/1Tc3xSdfV2

[Christman Lab @ChristmanLab]

@UChicagoPME @YingShirleyMeng @argonne congrats @YingShirleyMeng!